Abstract
Advanced leads from a series of 1,2,4-triazolo[4,3-a]pyridines with mGlu2 receptor PAM activity are reported. By modification of the analogous imidazo[1,2-a]pyridine series, the newly reported leads have improved potency, in vitro ADMET, and hERG as well as good in vivo PK profile. The optimization of the series focused on improving metabolic stability while controlling lipophilicity by introducing small modifications to the scaffold substituents. Analysis of this series combined with our previously reported mGlu2 receptor PAMs showed how lipophilic ligand efficiency was improved during the course of the program. Among the best compounds, example 20 (JNJ-42153605) showed a central in vivo efficacy by inhibition of REM sleep state at a dose of 3 mg/kg po in the rat sleep-wake EEG paradigm, a phenomenon shown earlier to be mGlu2 mediated. In mice, compound 20 reversed PCP-induced hyperlocomotion with an ED₅₀ of 5.4 mg/kg sc, indicative of antipsychotic activity.
MeSH terms
-
Allosteric Regulation
-
Animals
-
Antipsychotic Agents / chemical synthesis*
-
Antipsychotic Agents / pharmacokinetics
-
Antipsychotic Agents / pharmacology
-
Blood-Brain Barrier / metabolism
-
Cell Line
-
ERG1 Potassium Channel
-
Electroencephalography
-
Ether-A-Go-Go Potassium Channels / antagonists & inhibitors
-
Humans
-
Hyperkinesis / drug therapy
-
Male
-
Mice
-
Microsomes, Liver / metabolism
-
Patch-Clamp Techniques
-
Polysomnography
-
Pyridines / chemical synthesis*
-
Pyridines / pharmacokinetics
-
Pyridines / pharmacology
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, Metabotropic Glutamate / metabolism*
-
Sleep / drug effects
-
Structure-Activity Relationship
-
Triazines / chemical synthesis*
-
Triazines / pharmacokinetics
-
Triazines / pharmacology
-
Wakefulness / drug effects
Substances
-
3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl(1,2,4)triazolo(4,3-a)pyridine
-
Antipsychotic Agents
-
ERG1 Potassium Channel
-
Ether-A-Go-Go Potassium Channels
-
KCNH2 protein, human
-
Pyridines
-
Receptors, Metabotropic Glutamate
-
Triazines
-
metabotropic glutamate receptor 2